skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi team,
What are your thoughts on PTQ's latest prospectus offering? Does the amount of shares dilutive, and what metrics are used to calculate one warrant to purchase two shares at 1.60$ up to 12 months? Am looking at purchasing shares on weakness as it's prospects look promising due to the rising number of Covid 19 cases and the possibility of the company being bought out perhaps within the next 12 months.
Many thanks,
Jean
Read Answer Asked by Jean on June 29, 2020
Q: What is your opinion on this Canadian company which has just announced its IPO?
Read Answer Asked by Roy on June 29, 2020
Q: Do you have a number as to what the vaccine revenue might be for COVID 19 ?
It looks like perhaps 50 or more will be splitting the pie, yet a lot of money for all I think.
I am tracking NVAX, SRNE, MRNA.
All are up astronomically, but perhaps will double
Or more from here. Do you guys own any ?
Is there an ETF that holds these vaccine company’s?
Would you buy any, if so which one or one’s ?
I see SRNE is up 26% in the first 8 minutes this morning.
Thanks
Read Answer Asked by Luc on June 25, 2020
Q: I've been watching this one for a while, ever since you compared it favourably within the context of alternative energy / solar stocks. Wednesday's "dip" turns out to have been driven by a class action lawsuit concerning alleged revenue manipulations.

The press release from the legal firm filing the class action has this to say:

"On June 17, 2020, Prescience Point Capital Management issued a report alleging, among other things, that 'at least 39%, or $205.3 million, of [Enphase's] reported U.S. revenue is fabricated.' The report also claimed, citing former employees, that 'a large portion of [the Company's] astronomical growth over the past two years is attributable to accounting gimmicks that artificially inflate revenue and profits.'"

What are your thoughts on Enphase in light of this news?

Also, I'm curious given your experience, are you able to share any insights on how class action lawsuits affect companies and their share performance -- at least, until the allegations are actually proven or rejected in court?

Please deduct as needed.

Kind regards
Read Answer Asked by Marc on June 22, 2020
Q: Hey guys. Looking to put some money to work in the health care and cyber security worlds. Im a buy and hold, long term investor so looking for long term compounders with really strong innovative business models and a good runway to grow. What would be your top two or 3 picks in each space for a 5-10 year time frame?
Read Answer Asked by Ryan on June 22, 2020
Q: First are ETFS and ISHARES the same ? i am consideing whichever is appropriate .
i ownPFE JNJ Gld . i guess they are okay paydividends and have some role in vaccine.
i would like to with these to an ETF. Going by your answers i would like to have ABBvie let go of PFE .
JNJ i see your concerns on legal issues however i am okay holding this So please recommend an ETFforthis
Also i would like an ETF FOR med insruments i woud like SYK DXCM ISRG or other companie that fit into this mix
Read Answer Asked by thambirajah on June 22, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!